Clinical Trials
6 trialsNCT00369070 2018-01-04
A Phase 2 Trial of AMG 706 or Bevacizumab in Combination With Chemo for Advanced NSCLC
Amgen
Phase 2 Terminated
NCT02629848 2015-12-14
Study of Motesanib (AMG 706) in Combination With Paclitaxel and Carboplatin for Advanced Non-Squamous Non-Small Cell Lung Cancer
Takeda
Phase 3 Terminated
NCT00356681 2015-10-15
A Study of AMG 706 or Bevacizumab, in Combination With Paclitaxel Chemotherapy, as Treatment for Breast Cancer
Amgen
Phase 2 Terminated
NCT00360867 2015-10-15
An Open Label Treatment Extension Study of AMG 706
Amgen
Phase 2 Terminated
NCT00460317 2015-09-07
MONET1-MOtesanib NSCLC Efficacy and Tolerability Study
Amgen
Phase 3 Terminated
NCT00101907 2014-03-20
Safety of AMG 706 Plus Panitumumab Plus Gemcitabine-Cisplatin in the Treatment of Patients With Advanced Cancer
Amgen
Phase 1 Terminated